A new mice study suggests CBD could prove “a potential preventive agent” during early-stage SARS-CoV-2 infection.
Story continues below
This advertisement has not loaded yet, but your article continues below.
While researchers out of Chicago and Louisville caution against making any leaps regarding how CBD would work with people, they do emphasize that the findings to date merit “future clinical trials.”
Investigators point out in the research article, published this week in Science Advances, that COVID-19 spread clearly illustrates new treatments to combat the virus are needed.
Despite recent vaccine availability, study authors write that the virus is spreading rapidly. The need for alternative treatments is particularly pressing “for populations with limited inclination or access to vaccines.”
Read full article on The Growth Op
